Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies

Weill Cornell Medical College, New York

University of Rochester, James P. Wilmot Cancer Center, Rochester

Georgetown University Medical Center, Washington D.C.

Charleston Hematology Oncology, Charleston

Collaborative Research Group LLC, Boynton Beach

Signal Point Clinical Research Center, LLC, Middletown

MD Anderson Cancer Center, Houston

Pacific Shores Medical Group, Long Beach

UC San Diego Moores Cancer Center, La Jolla

Ventura County Hematology Oncology Specialists, Oxnard

Cancer Center of Santa Barbara, Santa Barbara

Oregon Health and Science University, Portland

Northwest Medical Specialties, Tacoma